<!DOCTYPE html>
<!-- Generated by Aspose.Words for .NET 22.7.0 --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-oc-2023-5-fr-docx</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel ">Ordonnance du DFI <br>sur les tableaux des stupéfiants, des substances psychotropes, des précurseurs et des adjuvants chimiques</h1>
<h2 class="erlasskurztitel ">(Ordonnance sur les tableaux des stupéfiants, OTStup-DFI)</h2>
<p>Modification du 21 décembre 2022</p>
</div>
<div id="preamble">
<p>Le Département fédéral de l’intérieur (DFI)</p>
<p>arrête:</p>
</div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I </a>
</h1>
<div class="collapseable">
<p>Les annexes 1, 3, 5, 6 et 7 de l’ordonnance du 30 mai 2011 sur les tableaux des stupéfiants<sup><a href="#fn-d6e24" id="fnbck-d6e24">1</a></sup> sont modifiées conformément aux textes ci-joints.</p>
<div class="footnotes"><p id="fn-d6e24"><sup><a href="#fnbck-d6e24">1</a></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2011/363" target="_blank">RS <b>812.121.11</b></a></p></div>
</div></section><section id="lvl_I_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I_I">II </a>
</h1>
<div class="collapseable">
<p>La présente ordonnance entre en vigueur le 1<sup>er</sup> mars 2023.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				<td>
					
					<p>21 décembre 2022</p>
				</td>
				<td>
					
					<p>Département fédéral de l’intérieur:</p>
					<p>Alain Berset</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex">
<section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Annexe 1 </a>
</h1>
<div class="collapseable">
<p>(art. 2, al. 1)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">Tableau général  des substances soumises à contrôle des tableaux a à d </a>
</h2>
<div class="collapseable">
<br><p class=" man-font-style-italic ">Ajouter les désignations suivantes dans le tableau dans l’ordre alphabétique:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Désignation</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>GTIN</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Tableau</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Brorphine</b><b><br></b>1-[1-[1-(4-bromophényl)éthyl]-pipéridine-4-yl]-1,3-<br>dihydro-2H-imidazole-2-one</p>
				</td>
				<td>
					
					<p>7611746013464</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Clonazolam</b><b><br></b>6-(2-chlorphényl)-1-méthyl-8-nitro-4H-s-triazol-<br>(4,3-a)-(1,4)-benzodiazépine</p>
				</td>
				<td>
					
					<p>7611746957850</p>
				</td>
				<td>
					
					<p>b</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Cumyl-Pegaclone</b><b><br></b>5-pentyl-2-(2-phénylpropan-2-yl)-2,5-dihydro-1H-<br>pyrido[4,3-b]indol-1-one</p>
				</td>
				<td>
					
					<p>7611746013624</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Diclazépam</b><b><br></b>7-chloro-5-(2-chlorophényl)-1,3-dihydro-1-méthyl-2H-1,4-benzodiazépine-2-one</p>
				</td>
				<td>
					
					<p>7611746013600</p>
				</td>
				<td>
					
					<p>b</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class=" man-font-weight-bold ">Diphénidine<br>1-(1,2-diphényléthyl)pipéridine</p>
				</td>
				<td>
					
					<p>7611746013938</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Eutylone</b><b><br></b>1-(1,3-benzodioxol-5-yl)-2-(éthylamino)butan-1-one</p>
				</td>
				<td>
					
					<p>7611746946199</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Flubromazolam</b><b><br></b>8-bromo-6-(2-fluorophényl)-1-méthyl-4H-<br>[1,2,4]triazolo[4,3-a][1,4]benzodiazépine</p>
				</td>
				<td>
					
					<p>7611746013617</p>
				</td>
				<td>
					
					<p>b</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Isotonitazène</b><b><br></b>N,N-diéthyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)éthan-1-amine</p>
				</td>
				<td>
					
					<p>7611746948322</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class=" man-font-weight-bold ">MDMB-4en-PINACA<br>Méthyl-2-[1-(pent-4-èn-1-yl)-1H-indazole-3-<br>carboxamido]-3,3-diméthylbutanoate</p>
				</td>
				<td>
					
					<p>7611746013785</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Métonitazène</b><b> </b><b><br></b>N,N-diéthyl-2-(2-(4-méthoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)éthan-1-amine</p>
				</td>
				<td>
					
					<p>7611746948483</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>3-méthoxyphéncyclidine</b><b><br></b>1-[1-(3-méthoxyphényl)cyclohexyl]-pipéridine, <br>3-MeO-PCP</p>
				</td>
				<td>
					
					<p>7611746013921</p>
				</td>
				<td>
					
					<p>d</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Rémimazolam</b></p>
				</td>
				<td>
					
					<p>7611746013761</p>
				</td>
				<td>
					
					<p>b</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Tramadol</b><b><br></b>Les médicaments prêts à l’emploi sont soustraits au contrôle. Les entreprises titulaires d’une autorisation d’exploitation permettant d’utiliser des substances soumises à contrôle figurant dans le tableau b ne sont pas soumises au contrôle ni pour la fabrication ni pour leur propre commerce intérieur ou leur propre exportation consécutifs.</p>
				</td>
				<td>
					
					<p>7611746013778</p>
				</td>
				<td>
					
					<p>b</p>
				</td>
			</tr>
			
		</table></div>
</div></section>
</div></section><section id="annex_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3">Annexe 3 </a>
</h1>
<div class="collapseable">
<p>(art. 2, al. 1)</p>
<section id="annex_3/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3/lvl_u1">Tableau b </a>
</h2>
<div class="collapseable">
<p class=" man-font-style-italic ">Ajouter les désignations suivantes dans le tableau dans l’ordre alphabétique:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Désignation</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class=" man-text-align-right ">GTIN</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Tableau</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Clonazolam</b><b><br></b>6-(2-chlorphényl)-1-méthyl-8-nitro-4H-s-triazol-<br>(4,3-a)-(1,4)-benzodiazépine</p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3357" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746957850<inl md="E" id="d6e3357" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3392" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>b<inl md="E" id="d6e3392" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Diclazépam</b><b><br></b>7-chloro-5-(2-chlorophényl)-1,3-dihydro-1-méthyl-2H-1,4-benzodiazépine-2-one</p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3501" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013600<inl md="E" id="d6e3501" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3536" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>b<inl md="E" id="d6e3536" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Flubromazolam</b><b><br></b>8-bromo-6-(2-fluorophényl)-1-méthyl-4<i>H</i>-<br>[1,2,4]triazolo[4,3-a][1,4]benzodiazépine</p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3677" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013617<inl md="E" id="d6e3677" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3712" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>b<inl md="E" id="d6e3712" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Rémimazolam</b></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3801" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013761<inl md="E" id="d6e3801" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3836" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>b<inl md="E" id="d6e3836" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Tramadol</b><b><br></b>Les médicaments prêts à l’emploi sont soustraits au contrôle. Les entreprises titulaires d’une autorisation d’exploitation permettant d’utiliser des substances soumises à contrôle figurant dans le tableau b ne sont pas soumises au contrôle ni pour la fabrication ni pour leur propre commerce intérieur ou leur propre exportation consécutifs.</p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3945" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013778<inl md="E" id="d6e3945" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p class=" man-text-align-right "><inl name="w:snapToGrid" md="S" id="d6e3980" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>b<inl md="E" id="d6e3980" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			
		</table></div>
</div></section>
</div></section><section id="annex_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5">Annexe 5 </a>
</h1>
<div class="collapseable">
<p>(art. 2, al. 1)</p>
<section id="annex_5/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5/lvl_u1">Tableau d </a>
</h2>
<div class="collapseable">
<p class=" man-font-style-italic ">Ajouter les désignations suivantes dans le tableau dans l’ordre alphabétique:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Désignation</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p class=" man-text-align-right ">GTIN</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Tableau</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Brorphine</b><b><br></b>1-[1-[1-(4-bromophényl)éthyl]-pipéridine-4-yl]-1,3-<br>dihydro-2H-imidazole-2-one</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4477" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013464<inl md="E" id="d6e4477" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4510" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e4510" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Cumyl-Pegaclone</b><b><br></b>5-pentyl-2-(2-phénylpropan-2-yl)-2,5-dihydro-1H-<br>pyrido[4,3-b]indol-1-one</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4630" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013624<inl md="E" id="d6e4630" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4663" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e4663" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class=" man-font-weight-bold ">Diphénidine<br>1-(1,2-diphényléthyl)pipéridine</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4769" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013938<inl md="E" id="d6e4769" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4802" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e4802" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Eutylone</b><b><br></b>1-(1,3-benzodioxol-5-yl)-2-(éthylamino)butan-1-one</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4909" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746946199<inl md="E" id="d6e4909" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e4942" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e4942" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Isotonitazène</b><b><br></b>N,N-diéthyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)éthan-1-amine</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5049" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746948322<inl md="E" id="d6e5049" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5082" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e5082" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p class=" man-font-weight-bold ">MDMB-4en-PINACA<br>Méthyl-2-[1-(pent-4-èn-1-yl)-1H-indazole-3-<br>carboxamido]-3,3-diméthylbutanoate</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5202" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013785<inl md="E" id="d6e5202" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5235" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e5235" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>Métonitazène</b><b> </b><b><br></b>N,N-diéthyl-2-(2-(4-méthoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)éthan-1-amine</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5356" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746948483<inl md="E" id="d6e5356" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5389" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e5389" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p><b>3-méthoxyphéncyclidine</b><b><br></b>1-[1-(3-méthoxyphényl)cyclohexyl]-pipéridine, <br>3-MeO-PCP</p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5510" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>7611746013921<inl md="E" id="d6e5510" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
				<td>
					
					<p><inl name="w:snapToGrid" md="S" id="d6e5545" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl>d<inl md="E" id="d6e5545" xmlns:tmp="urn:com:c-moria:legi4ch:xslt:temp"></inl></p>
				</td>
			</tr>
			
		</table></div>
</div></section>
</div></section><section id="annex_6"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_6">Annexe 6 </a>
</h1>
<div class="collapseable">
<p>(art. 2, al. 2)</p>
<section id="annex_6/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_6/lvl_u1">Tableau e: Matières premières et produits ayant un effet présumé semblable à celui des stupéfiants </a>
</h2>
<div class="collapseable">
<br><p class=" man-font-style-italic ">Ch. 104, 134, 138, 176, 201, 224 et 273</p>
<p class=" man-font-style-italic ">Abrogés</p>
</div></section>
</div></section><section id="annex_7"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_7">Annexe 7 </a>
</h1>
<div class="collapseable">
<p>(art. 2, al. 3)</p>
<section id="annex_7/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_7/lvl_u1">Tableau f: Précurseurs </a>
</h2>
<div class="collapseable">
<p class=" man-font-style-italic ">Ajouter les ch. 27, 28 et 29 dans le tableau:</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Numéro</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Désignation</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p>27</p>
				</td>
				<td>
					
					<p class=" man-font-weight-bold ">N-Phényl-4-pipéridinamine (4-AP, 4-anilinopipéridine)</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>28</p>
				</td>
				<td>
					
					<p class=" man-font-weight-bold ">Tert-butyl 4-(phénylamino)pipéridin-1-carboxylate <br>(1-boc-4-anilinopipéridine, 1-boc-4-AP)</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>29</p>
				</td>
				<td>
					
					<p class=" man-font-weight-bold ">Norfentanyl (N-phényl-N-(pipéridin-4-yl)propionamide)</p>
				</td>
			</tr>
			
		</table></div>
<p></p>
</div></section>
</div></section>
</div>
</div></body>
</html>
